Piscataway, NJ 12/27/17—Gene synthesis service provider GenScript Biotech has agreed to purchase CustomArray for an undisclosed amount. CustomArray supplies customized oligonucleotide pools and microarrays. “The acquisition of CustomArray further strengthens our synthetic biology product portfolio with a unique technology that we believe will enhance our customers’ ability to accelerate innovation in drug discovery and development, genome editing, protein engineering and synthetic biology,” stated GenScript CEO Frank Zhang, PhD.

With the acquisition, GenScript Biotech adds a proprietary technology for in situ synthesis of oligonucleotide microarrays. GenScript also sells life science research products. CustomArray’s two array products allow the production of either 12,000 or 90,000 oligonucleotides on an array and are available at a cost effective price, according to the company’s website.